Efficacy News and Research

RSS
Insilico Medicine nominates novel preclinical candidate targeting 3CL protease for COVID-19 treatment

Insilico Medicine nominates novel preclinical candidate targeting 3CL protease for COVID-19 treatment

Novel ultrasound-assisted laser technique removes arterial plaque safely and efficiently

Novel ultrasound-assisted laser technique removes arterial plaque safely and efficiently

Use of computer-aided technology during colonoscopy increases adenoma detection rate

Use of computer-aided technology during colonoscopy increases adenoma detection rate

NIH awards first part of $30 million grant to USC team for stroke project

NIH awards first part of $30 million grant to USC team for stroke project

Hamster contact exposure challenge model assesses protection conferred by SARS-CoV-2 vaccination or prior infection against reinfection

Hamster contact exposure challenge model assesses protection conferred by SARS-CoV-2 vaccination or prior infection against reinfection

Findings from the CoVaccS study on parental intention to vaccinate children against COVID

Findings from the CoVaccS study on parental intention to vaccinate children against COVID

Efficacy study of Paxlovid and Molnupiravir in real-world settings shows positive results

Efficacy study of Paxlovid and Molnupiravir in real-world settings shows positive results

Anti-SARS-CoV-2 antibodies persist in breast milk, even after gastrointestinal digestion

Anti-SARS-CoV-2 antibodies persist in breast milk, even after gastrointestinal digestion

SARS-CoV-2 mRNA vaccines do not stimulate interferon stimulatory gene expression in Aicardi Goutières Syndrome patients

SARS-CoV-2 mRNA vaccines do not stimulate interferon stimulatory gene expression in Aicardi Goutières Syndrome patients

Real-world vaccine effectiveness of mRNA-1273 and BNT1262b2 in immunocompromised adults

Real-world vaccine effectiveness of mRNA-1273 and BNT1262b2 in immunocompromised adults

Pfizer COVID-19 vaccine-associated tinnitus responds to transcranial magnetic stimulation

Pfizer COVID-19 vaccine-associated tinnitus responds to transcranial magnetic stimulation

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Unmarried heart failure patients lack confidence to manage their condition, study says

Unmarried heart failure patients lack confidence to manage their condition, study says

Study reveals how ZBP1 could lead to a cytokine storm during COVID-19

Study reveals how ZBP1 could lead to a cytokine storm during COVID-19

Important methodology for targeting conserved epitopes of SARS-CoV-2 and an immune-focused approach in pan-sarbeco and universal CoV vaccine design

Important methodology for targeting conserved epitopes of SARS-CoV-2 and an immune-focused approach in pan-sarbeco and universal CoV vaccine design

Study demonstrates that ATV006 is orally bioavailable and has potent efficacy against SARS-CoV-2

Study demonstrates that ATV006 is orally bioavailable and has potent efficacy against SARS-CoV-2

Multi-center trial shows promising results for implant-free interatrial shunt device to treat heart failure patients

Multi-center trial shows promising results for implant-free interatrial shunt device to treat heart failure patients

Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19

Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Low-dose apixaban treatment reduces recurrence of venous thromboembolism compared to anticoagulant discontinuation after negative D-dimer

Ensitrelvir demonstrates swift SARS-CoV-2 clearance and safety among individuals with asymptomatic, mild, or moderate SARS-CoV-2 infections

Ensitrelvir demonstrates swift SARS-CoV-2 clearance and safety among individuals with asymptomatic, mild, or moderate SARS-CoV-2 infections

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.